These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring. Rengarajan A; Savarino E; Della Coletta M; Ghisa M; Patel A; Gyawali CP Clin Gastroenterol Hepatol; 2020 Mar; 18(3):589-595. PubMed ID: 31163276 [TBL] [Abstract][Full Text] [Related]
3. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial. Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568 [TBL] [Abstract][Full Text] [Related]
4. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease. Januszewicz W; Hartley J; Waldock W; Roberts G; Alias B; Hobson A; Wernisch L; di Pietro M United European Gastroenterol J; 2019 Dec; 7(10):1389-1398. PubMed ID: 31807307 [TBL] [Abstract][Full Text] [Related]
5. The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring. Kushnir VM; Sayuk GS; Gyawali CP Dig Dis Sci; 2011 May; 56(5):1412-9. PubMed ID: 21046245 [TBL] [Abstract][Full Text] [Related]
6. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo Schey R; Alla SP; Midani D; Parkman HP Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467 [TBL] [Abstract][Full Text] [Related]
8. Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy. Yadlapati R; Gyawali CP; Masihi M; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE Am J Gastroenterol; 2022 Oct; 117(10):1573-1582. PubMed ID: 35973148 [TBL] [Abstract][Full Text] [Related]
9. Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements. Yadlapati R; Gawron AJ; Gyawali CP; Chen J; Clarke J; Fass R; Jain A; Lynch K; Khan A; Katz PO; Katzka DA; Richter J; Schnoll-Sussman F; Spechler SJ; Vaezi MF; Vela M; Pandolfino JE Aliment Pharmacol Ther; 2022 Oct; 56(8):1274-1283. PubMed ID: 35971888 [TBL] [Abstract][Full Text] [Related]
10. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844 [TBL] [Abstract][Full Text] [Related]
11. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200 [TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]